Cargando…
Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaques
BACKGROUND: Vaginal products for HIV prevention that can be used on-demand before or after sex may be a preferable option for women with low frequency or unplanned sexual activity or who prefer not to use daily or long-acting pre-exposure prophylaxis (PrEP). We performed dose ranging pharmacokinetic...
Autores principales: | Dobard, Charles W., Peet, M. Melissa, Nishiura, Kenji, Holder, Angela, Dinh, Chuong, Mitchell, James, Khalil, George, Pan, Yi, Singh, Onkar N., McCormick, Timothy J., Agrahari, Vivek, Gupta, Pardeep, Jonnalagadda, Sriramakamal, Heneine, Walid, Clark, Meredith R., García-Lerma, J. Gerardo, Doncel, Gustavo F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691909/ https://www.ncbi.nlm.nih.gov/pubmed/36423375 http://dx.doi.org/10.1016/j.ebiom.2022.104361 |
Ejemplares similares
-
Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaques
por: Makarova, Natalia, et al.
Publicado: (2022) -
The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques
por: Daly, Michele B., et al.
Publicado: (2020) -
Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques
por: Dobard, Charles W, et al.
Publicado: (2015) -
Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV
por: Devred, Inès, et al.
Publicado: (2023) -
A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir
por: Thurman, Andrea R., et al.
Publicado: (2023)